AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06662903 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Cranioplasty with Titanium mesh
Description: Cranioplasty using titanium mesh
Study NCT06662903 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Cranioplasty with bone cement
Description: Cranioplasty using bone cement
Study NCT06664463 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Arousal enhancment protocol
Description: Auditory stimulation: Playing familiar music or personalized playlists tailored to the patient's preferences evokes emotional responses and promotes arousal.~Olfactory stimulation: Using essential oils or fragrances associated with calming or invigorating properties fosters emotional connections and evokes nostalgia through scents linked to positive memories.~Visual stimulation: Displaying photographs of family members or significant events provides comforting visual stimulation and stimulates visual awareness.~Tactile stimulation: Gentle touch or therapeutic massage engages the patient through tactile input, promoting physiological and emotional responses.~Besid thsi protocl also the will recivce routine care throughout study period The control group in this study will receive routine hospital care. This care includes standard medical evaluations, monitoring of vital signs, neurological assessments, and any necessary imaging (such as CT or MRI scans). Patients will also receive s
Study NCT06664463 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Routine Care
Description: The control group in this study will receive routine hospital care. This care includes standard medical evaluations, monitoring of vital signs, neurological assessments, and any necessary imaging (such as CT or MRI scans). Patients will also receive supportive care, including pain management, hydration, and nutrition, as well as physical, occupational, or speech therapy as needed based on their recovery progress
Study NCT06664086 — intervention group
Intervention type: BEHAVIORAL
Intervention: economic and psychological burden
Description: measuring the economic and psychological burden of infertility
Study NCT06664216 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: incorrect trocar placement marks.
Description: Participants in the experimental group will perform trocar placements on laparoscopic models that have been pre-marked with incorrect insertion sites by previous participants. These marks simulate procedural steps or anatomical landmarks that are intentionally incorrect.
Study NCT06664216 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: incorrect trocar placement marks.
Description: Participants in the experimental group will perform trocar placements on laparoscopic models that have been pre-marked with incorrect insertion sites by previous participants. These marks simulate procedural steps or anatomical landmarks that are intentionally incorrect.
Study NCT06664008 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: PPI (proton pump inhibitor)
Description: It reduces stomach acid production and manage GERD symptoms
Study NCT06664008 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PPI (proton pump inhibitor)
Description: It reduces stomach acid production and manage GERD symptoms
Study NCT06664008 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Probiotic
Description: Live microorganisms, primarily bacteria and yeast, that are believed to provide health benefits when consumed in adequate.
Study NCT06664008 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zinc
Description: Zinc used a supplement due to its role in decreasing inflammation of the gastroesophageal reflux disease.
Study NCT06663267 — intervention group
Intervention type: OTHER
Intervention: NOT
Description: This retrospective cohort study involves no new interventions. It analyzes existing health data collected from subjects exposed to varying atmospheric conditions to assess impacts on health outcomes.
Study NCT06664359 — intervention group
Intervention type: OTHER
Intervention: Ultrasound guided injection with local anaestethic
Description: Volunteers will first be asked to sit on a chair with their back facing the examiner, placing their arms in a relaxed position with their head supported on a surface in front of them. The ultrasound operator will be positioned behind the volunteer. Initially, in the sitting position, volunteers will be asked to maintain normal breathing. Once an optimal ultrasound image is obtained, the image will be frozen, and measurements will be taken from the same image in sequence. The measurements to be performed are as follows: skin-fat tissue distance, skin-trapezius muscle distance, skin-rhomboid muscle distance, skin-rib distance, skin-pleura distance, and rhomboid muscle-pleura distance. These measurements, in millimeters, will be recorded in the data collection form. The same measurements will also be taken during deep inhalation and deep exhalation in the sitting position.
Study NCT04821076 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise intervention
Description: Exercise will consist of supervised resistance training, interval training and moderate intensity cycling
Study NCT06664359 — intervention group
Intervention type: OTHER
Intervention: Ultrasound guided injection with local anaestethic
Description: Volunteers will first be asked to lay prone position.The ultrasound operator will be positioned behind the volunteer. Initially, in the sitting position, volunteers will be asked to maintain normal breathing. Once an optimal ultrasound image is obtained, the image will be frozen, and measurements will be taken from the same image in sequence. The measurements to be performed are as follows: skin-fat tissue distance, skin-trapezius muscle distance, skin-rhomboid muscle distance, skin-rib distance, skin-pleura distance, and rhomboid muscle-pleura distance. These measurements, in millimeters, will be recorded in the data collection form. The same measurements will also be taken during deep inhalation and deep exhalation in the sitting position.
Study NCT06223672 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Walnuts
Description: 56g of walnuts consumed each day for 7 days
Study NCT06223672 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Simply White Diary-free chocolate bar
Description: 68g of the white chocolate style-bar each day for 7 days
Study NCT05304858 — intervention group
Intervention type: PROCEDURE
Intervention: Biopsy
Description: Standard of care surgical procedures to collect prostate cancer tissue from men with metastatic prostate cancers. Non-experimental.
Study NCT05654324 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: pelvic floor muscle exercises
Description: Before the pelvic floor exercises are taught to all women participating in the study, a brief informational training about the function and structure of the pelvic floor and pelvis will be given using visuals. The application protocol will be given by experienced specialist physiotherapists who have received special training on pelvic floor muscle training. In this study, the training protocol described by Mørkved et al and Bø et al will be used. An exercise series will consist of slow and fast muscle contractions of the pelvic floor muscles. The exercise series will include 10 reps of maximum pelvic floor muscle contraction held for 6 seconds followed by three rapid muscle contractions. A 10-second rest period will be given between each exercise series. A total of 5 minutes, 4 repetitions of pelvic floor muscle contraction series will be applied, including the rest period.
Study NCT05654324 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: pelvic floor muscle exercises
Description: Before the pelvic floor exercises are taught to all women participating in the study, a brief informational training about the function and structure of the pelvic floor and pelvis will be given using visuals. The application protocol will be given by experienced specialist physiotherapists who have received special training on pelvic floor muscle training. In this study, the training protocol described by Mørkved et al and Bø et al will be used. An exercise series will consist of slow and fast muscle contractions of the pelvic floor muscles. The exercise series will include 10 reps of maximum pelvic floor muscle contraction held for 6 seconds followed by three rapid muscle contractions. A 10-second rest period will be given between each exercise series. A total of 5 minutes, 4 repetitions of pelvic floor muscle contraction series will be applied, including the rest period.
Study NCT06618599 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Mid-transverse process to pleura block combined with erector spinae block
Description: The probe will be placed vertically 3 cm lateral to the T5 spinous process and the transverse process will be identified. The needle will be introduced in an in-plane fashion until the tip lay deep in the erector spinae muscle. One milliliter of normal saline will be injected to confirm the correct needle tip position by visualizing the spread under the erector spinae muscle. 20 mL of 0.25% bupivacaine will be injected .The needle will be directed aiming for the midpoint between the transverse process and pleura from cephalad to caudad. One milliliter of normal saline will be given to confirm the position of the needle tip, then a total of 20 ml of 0.25% ropivacaine will be injected
Study NCT06618599 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: paravertebral block
Description: the transducer will be positioned laterally 3 cm to the midline at T5 spinous process, defining the spinous process, pleura, transverse process, the paravertebral (PV) space, and superior costotransverse ligament. The trapezius, rhomboid major, and erector spinae muscles will be recognized as superficial to the hyperechoic transverse process shadow. However, when the rhomboid major muscle disappeared, this indicated that we will be at the 7th thoracic vertebra's level. Local infiltration using 2-3 mL of 2.0% lignocaine will be done. A spinal 22-gauge needle will be injected at the cephalic side of the transducer using an in-plane technique, and the needle directed towards the costotransverse ligament (CTL). The passage of the needle through the CTL will be associated with a pop, informing that the superior costotransverse ligament will be passed. Following a 3 mL testing dose of normal saline containing epinephrine (1:200,000), 30 mL bupivacaine 0.25% injected.
Study NCT06523270 — intervention group
Intervention type: RADIATION
Intervention: Computed Tomography (CT) using Photon Counting CT scanner (Neaotom Alpha, Siemens) and Magnetic Resonance (MRI)
Description: All adult (≥18 y.o) subjects (until 50000 individuals) presenting to the U.O of Radiologia DiMer Advanced Imaging for Personalized Medicine to be submitted to imaging study on advanced scanner
Study NCT04729504 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Adapted Project BRAVE
Description: A culturally and linguistically adapted Project BRAVE is web-based single session intervention that is about 30 minutes in length. The session is designed to focus on targeting child anxiety symptoms in the multilingual and diverse families in Miami-Dade.
Study NCT05429112 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Flexible Tip Bougie
Description: Patients randomised to Flexible Tip Bougie will be intubated with a Videolaryngoscopy and with a Flexible Tip Bougie.
Study NCT05429112 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Endotracheal Tube with Stylet
Description: Patients randomised to Endotracheal Tube with Stylet will be intubated with a Videolaryngoscopy and with a endotracheal tube + stylet.
Study NCT04800822 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-07284892
Description: PF-07284892
Study NCT04800822 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: lorlatinib
Description: lorlatinib
Study NCT04800822 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: binimetinib
Description: binimetinib
Study NCT04800822 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: cetuximab
Description: cetuximab
Study NCT04800822 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: encorafenib
Description: encorafenib
Study NCT03828344 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: hUC-MSC suspension
Description: Patients will be treated at dose of 0.75×10\^6 cells/kg of body weight (Cohort 1) or 1.5×10\^6 cells/kg of body weight (Cohort 2) via a single IV infusion using a blood transfusion kit.
Study NCT03828344 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo contains the same cell suspension as BX-U001 but without cells.
Study NCT04645732 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Personalized exercise therapy and self-management support program
Description: See description under Arms
Study NCT04645732 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Usual care
Description: See description under Arms
Study NCT04645732 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual care
Description: See description under Arms
Study NCT04809129 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Weighted vest
Description: Patients will wear a weighted vest following bariatric surgery with weight increased incrementally to maintain baseline weight. This vest will be worn for a minimum of 8 hours a day for three months postoperatively.
Study NCT06005025 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Reminder message
Description: Experimental group will be counselled for 6 months after the training and a reminder message will be sent via SMS on Monday every week as Check your modifiable risk factors for breast cancer and their feedback will be received.
Study NCT06280313 — intervention group
Intervention type: COMBINATION_PRODUCT
Intervention: Splenectomy+Targeted therapy+ Immunotherapy
Description: Eligible patients with unresectable hepatocellular carcinoma accompanied by cirrhotic portal hypertension were enrolled in the trial, and all participants underwent either open or laparoscopic splenectomy, with or without devascularization around the cardia. Starting two weeks post-surgery, patients began intravenous infusion of PD-1 monoclonal antibody, Tislelizumab, at a dosage of 200mg every three weeks. Three weeks post-surgery, patients commenced oral administration of the targeted therapy, Lenvatinib, with a dosage based on body weight: 8mg (≤60kg) or 12mg (>60kg), once daily.
Study NCT04928222 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Doxorubicin-containing MNA
Description: A 15 x 15 millimeter array containing 400 dissolvable microneedles delivering active agent
Study NCT04928222 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo-containing MNA
Description: A 15 15 x 15 millimeter array containing 400 dissolvable microneedles containing placebo
Study NCT05724004 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: SBRT/SRS/radiation therapy
Description: Consolidation radiation therapy (SBRT/SRS/moderately hypofractionated radiation therapy)
Study NCT04821076 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise intervention
Description: Exercise will consist of supervised resistance training, interval training and moderate intensity cycling
Study NCT04821076 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Diet intervention - Energy balance
Description: Energy balance is set to 50 kcal / kg fat-free mass
Study NCT03425786 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Diagnostic training
Description: Training in the Dix-Hallpike maneuver and the supine head roll test to diagnose BPPV.
Study NCT03425786 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Diagnostic and treatment training
Description: Training in the Dix-Hallpike maneuver and the supine head roll test to diagnose BPPV. Training in the Epley and Barbecue maneuvers to treat BPPV.
Study NCT06162117 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: 2- Minute Step Test
Description: 2- Minute Step Test will be administered to patients with traumatic meniscus tear
Study NCT06469047 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Enzyme-linked immunosorbent assay
Description: Serum N/OFQ , IL-1β and NE levels were detected.
Study NCT02718105 — intervention group
Intervention type: GENETIC
Intervention: KIR HLAC determinations
Description: We will take blood samples for KIR HLA-C determinations.
Study NCT06014112 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Freestyle Libre Pro iQ
Description: Freestyle Libre Pro iQ is a professional sensor, marketed by the Abbott laboratory, for continuous, non-invasive interstitial glucose measurement allowing the recording of glycemic parameters for 2 weeks.~The study will be offered to any subject with an ACS. The installation of the Freestyle Libre Pro iQ sensor will be performed upon admission to intensive care Cardiology and left in place for the duration of hospitalization. In case of the Freestyle Libre Pro iQ sensor defective or removed before discharge from hospital, and if the patient tolerates it, a new the Freestyle Libre Pro iQ sensor will be placed. If the duration of hospitalization exceeds 14 days, a 2nd sensor will be placed.
Study NCT05514834 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cellular Matrix TM BCT-HA Kit (ref. BCT-HA-3)
Description: Injections with platelet-rich plasma and hyaluronic acid
Study NCT05514834 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: PRP Only
Description: platelet rich plasma without hyaluronic acid
Study NCT05514834 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Neither PRP nor hyaluronic acid
Study NCT06529328 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: core stability
Description: In this study the experimental group will perform core stability exercises 3 times per week for an 8-week period and each session of 30 to 45 minutes, the core stability exercises will work on abdominals and trunk muscles with challenges.Subjects received 25 min conventional therapy in addition to 30 30-minute trunk stabilization exercise program conducted for 3 days\\week on non-consecutive days.~Passive stretching exercises are applied to all tight muscles, including the hamstrings and calf muscles in the lower limb. It is performed five times initially, building up to ten repetitions, stretching for 5 times, and then allowing relaxation for 5time. Strengthening exercises for back, hip, and knee extensor muscles (for 10 minutes).
Study NCT06166953 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: digital technology-supported education
Description: The education will include information about surgical process and care after surgery.
Study NCT06161038 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: LASER
Description: LLLT with a 685-nm wavelength and an output of 30 mW (BTL-5000 Laser, BTL, Stevenage, UK) at energy densities of 8 J/cm2 at trigger point of upper trapezius muscle.
Study NCT06161038 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Ultrasound
Description: 1 MHz therapeutic ultrasound for 5 min at a frequency of 4-6 times two week at the painful upper trapezius muscle.
Study NCT06161038 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Prolotherapy
Description: Hypertonic prolotherapy at perimysium of upper trapezius muscle. The injectant is 5ml 5% dextrose solution.
Study NCT05992285 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: transcranial magnetic stimulation
Description: the intensity of stimulus was 80% Resting motor threshold(RMT); the frequency of trains was 50 Hz and the number of pulses was three; and the frequency of intertrain intervals was 5 Hz and pulses number was 200. Two groups were repeatedly stimulated in the dentate nucleus of bilateral cerebellum, the interval of each group was 5min, and the number of stimulation pulses at each site was 1200.
Study NCT05992285 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: transcranial magnetic stimulation
Description: the intensity of stimulus was 80% Resting motor threshold(RMT); the frequency of trains was 50 Hz and the number of pulses was three; and the frequency of intertrain intervals was 5 Hz and pulses number was 200. Two groups were repeatedly stimulated in the dentate nucleus of bilateral cerebellum, the interval of each group was 5min, and the number of stimulation pulses at each site was 1200.
Study NCT05610813 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VER-01
Description: Standardized oleoresin of Cannabis sativa L. folium cum flore, THC-chemotype (cannabis leaves and - flowers), corresponding to 21 mg (-)-trans-Δ9-Tetra-hydrocannabinol (THC) per gram drug product
Study NCT05610813 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Opioid therapy
Description: The patient-specific selection of the marketed opioid (based on standard of care and provided for this study) is at the discretion of the investigator and made at Visit 1, i.e., before randomization at Visit 2.
Study NCT06402513 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ravagalimab
Description: Subcutaneous Injection
Study NCT03895827 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Recovery Initiation and Management after Overdose (RIMO)
Description: RIMO uses motivational interviewing and linkage assistance techniques to get people who have had a recent opioid overdose reversal to go to medication-assisted treatment (MAT), stay in MAT, and, if they drop out, go back to MAT treatment.
Study NCT03895827 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Passive Referral to Treatment Control
Description: Currently neither first responders or emergency department staff regularly refer people to any kind of substance use after an opioid overdose reversal. In the passive referral condition they will at least get a brochure with information on recently expanded and publicly-funded medication-assisted treatment in their community.